Free Trial

Connect Biopharma (CNTB) Competitors

Connect Biopharma logo
$2.06 +0.30 (+17.05%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$2.12 +0.06 (+3.16%)
As of 08/29/2025 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CNTB vs. CRVS, KMDA, AURA, IMAB, YMAB, AQST, VIGL, OLMA, RCKT, and ZYBT

Should you be buying Connect Biopharma stock or one of its competitors? The main competitors of Connect Biopharma include Corvus Pharmaceuticals (CRVS), Kamada (KMDA), Aura Biosciences (AURA), I-Mab (IMAB), Y-mAbs Therapeutics (YMAB), Aquestive Therapeutics (AQST), Vigil Neuroscience (VIGL), Olema Pharmaceuticals (OLMA), Rocket Pharmaceuticals (RCKT), and Zhengye Biotechnology (ZYBT). These companies are all part of the "pharmaceutical products" industry.

Connect Biopharma vs. Its Competitors

Connect Biopharma (NASDAQ:CNTB) and Corvus Pharmaceuticals (NASDAQ:CRVS) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, dividends, earnings, analyst recommendations, valuation and risk.

Connect Biopharma presently has a consensus price target of $7.00, indicating a potential upside of 239.81%. Corvus Pharmaceuticals has a consensus price target of $15.00, indicating a potential upside of 161.32%. Given Connect Biopharma's stronger consensus rating and higher possible upside, equities research analysts clearly believe Connect Biopharma is more favorable than Corvus Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Connect Biopharma
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.50
Corvus Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Connect Biopharma had 3 more articles in the media than Corvus Pharmaceuticals. MarketBeat recorded 5 mentions for Connect Biopharma and 2 mentions for Corvus Pharmaceuticals. Corvus Pharmaceuticals' average media sentiment score of 1.62 beat Connect Biopharma's score of 0.41 indicating that Corvus Pharmaceuticals is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Connect Biopharma
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Corvus Pharmaceuticals
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

58.7% of Connect Biopharma shares are owned by institutional investors. Comparatively, 46.6% of Corvus Pharmaceuticals shares are owned by institutional investors. 22.6% of Connect Biopharma shares are owned by company insiders. Comparatively, 28.5% of Corvus Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Connect Biopharma has a beta of -0.09, suggesting that its share price is 109% less volatile than the S&P 500. Comparatively, Corvus Pharmaceuticals has a beta of 0.42, suggesting that its share price is 58% less volatile than the S&P 500.

Connect Biopharma's return on equity of 0.00% beat Corvus Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Connect BiopharmaN/A N/A N/A
Corvus Pharmaceuticals N/A -28.61%-18.05%

Connect Biopharma has higher revenue and earnings than Corvus Pharmaceuticals.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Connect Biopharma$26.03M4.41-$15.63MN/AN/A
Corvus PharmaceuticalsN/AN/A-$62.29M-$1.01-5.68

Summary

Connect Biopharma beats Corvus Pharmaceuticals on 9 of the 13 factors compared between the two stocks.

Get Connect Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for CNTB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CNTB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CNTB vs. The Competition

MetricConnect BiopharmaMED IndustryMedical SectorNASDAQ Exchange
Market Cap$114.79M$3.07B$5.75B$9.76B
Dividend YieldN/A2.29%4.10%4.04%
P/E RatioN/A20.7883.2726.59
Price / Sales4.41386.79535.03111.31
Price / CashN/A44.2237.4459.26
Price / Book1.618.0710.556.58
Net Income-$15.63M-$53.98M$3.27B$265.95M
7 Day Performance12.57%-0.88%0.40%0.17%
1 Month Performance1.98%7.72%7.31%3.90%
1 Year Performance28.75%7.03%46.58%19.67%

Connect Biopharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CNTB
Connect Biopharma
3.261 of 5 stars
$2.06
+17.0%
$7.00
+239.8%
+28.8%$114.79M$26.03M0.00110Upcoming Earnings
CRVS
Corvus Pharmaceuticals
3.1581 of 5 stars
$5.45
-1.8%
$15.00
+175.2%
+28.1%$406.10MN/A-5.4030Positive News
KMDA
Kamada
4.6482 of 5 stars
$7.05
-1.8%
$13.00
+84.4%
+20.3%$405.45M$160.95M20.74360Positive News
AURA
Aura Biosciences
1.7128 of 5 stars
$6.52
-0.5%
$22.00
+237.4%
-21.3%$405.02MN/A-3.3350Positive News
IMAB
I-Mab
2.9551 of 5 stars
$4.82
-5.3%
$6.50
+34.9%
+268.1%$393.60M$3.89M0.00380Positive News
Analyst Forecast
High Trading Volume
YMAB
Y-mAbs Therapeutics
2.4635 of 5 stars
$8.52
-0.1%
$9.62
+12.9%
-40.3%$387.13M$85.39M-17.04150
AQST
Aquestive Therapeutics
2.0408 of 5 stars
$3.86
-3.0%
$10.14
+162.8%
-16.8%$384.94M$44.13M-5.51160Positive News
VIGL
Vigil Neuroscience
1.3003 of 5 stars
$8.05
flat
$10.80
+34.2%
N/A$383.91MN/A-3.9340
OLMA
Olema Pharmaceuticals
2.0404 of 5 stars
$5.59
-3.0%
$24.00
+329.3%
-53.7%$383.64MN/A-2.8270News Coverage
RCKT
Rocket Pharmaceuticals
4.9013 of 5 stars
$3.54
-2.7%
$16.73
+372.7%
-82.6%$381.98MN/A-1.41240
ZYBT
Zhengye Biotechnology
N/A$8.00
+14.6%
N/AN/A$377.36M$25.53M0.00278News Coverage
Gap Down

Related Companies and Tools


This page (NASDAQ:CNTB) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners